Accelerating nerve regeneration with botulinum toxin and electrical stimulation therapies
Accelerating nerve regeneration with botulinum toxin and electrical stimulation therapies
批准号:
10383674
负责人:
Colin Franz
金额:
$16.18万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-05 至 2024-03-31
关键词:
AcuteAddressAdultAnatomyAxonBehaviorBotulinum Toxin Type ABotulinum ToxinsClinicClinicalClinical ResearchClinical TrialsDistalDoseElectric StimulationElectric Stimulation TherapyElectrophysiology (science)EventFDA approvedFoundationsFractureFutureGoalsGunshot woundHumanImplantIn VitroIncidenceInjuryIntramuscular InjectionsLeftLesionLimb structureMeasuresModelingMonitorMuscleNatural regenerationNerveNerve CrushNerve RegenerationNeuronsOperative Surgical ProceduresOrganOutcomeParalysedPathway interactionsPatientsPeripheral nerve injuryPharmaceutical PreparationsPhasePostoperative PeriodProcessProteinsProtocols documentationPublic HealthRandomized Clinical TrialsRecoveryRecovery of FunctionRehabilitation therapyRodentScientistSiteSkinSpeedStructure of tibial nerveSubgroupSystemTechnologyTestingTimeTracerTransgenic MiceTraumaVisualizationWorkaxon regenerationbaseclinical implementationclinically relevantdrug repurposingexperimental studyfollow-upfunctional disabilityfunctional outcomeship bonehip replacement arthroplastyimprovedin vivolimb amputationmuscle reinnervationnerve gapnerve injurynerve repairneuromuscularnovelnovel therapeuticsopen woundpainful neuropathyrepair modelrepairedsciatic nerve lesiontreatment strategywireless
中文摘要
项目摘要
周围神经损伤是一个被低估的公共卫生问题。约有
美国每年新增20万例。绝大多数患者的恢复不完全
因为神经再生缓慢且效率低下。不幸的是,
改善神经再生过程的治疗方法。我们已经确定了两个
互补疗法,以便针对神经的(i)早期和(ii)晚期
再生过程它们都可以作为独立的治疗或潜在的
组合,正如我们预测的那样,它们将对神经修复有额外的好处。本
该提案将为后续临床试验奠定基础,以将最有希望的治疗方法带到
患者我们相信我们可以朝着这个目标取得快速进展,因为一种治疗方法
代表了一种已经FDA批准的药物的再利用,另一种疗法是一种形式,
电刺激已经在神经损伤的小型临床试验中显示出有效性。的
电刺激治疗需要一种新的输送模式,以消除临床治疗的障碍。
实现,我们提供了通过新的瞬态生物电植入系统。总的来说,
这项提案将为我们如何改善对患有
周围神经损伤,以最大限度地恢复功能。
英文摘要
Project Summary
Peripheral nerve injuries are an under-appreciated public health problem. There are about
200,000 new cases per year in the USA. Recovery is incomplete for the vast majority of patients
who suffer from one because nerve regrowth is slow and inefficient. Unfortunately, there are no
approved treatments to improve the process of nerve regeneration. We have identified two
complimentary therapies in order to target the (i) early and (ii) late phases of the nerve
regeneration process. They each may work as stand-alone therapy or potentially in
combination, as we predict they will have an additive benefit on nerve repair. The present
proposal will set the stage for a follow up clinical trial to bring the most promising therapy to
patients. We believe we can make rapid progress towards this goal because one therapy
represents a repurposing of an already FDA-approved drug, and the other therapy is a form of
electrical stimulation that already has shown efficacy in small clinical trials for nerve injury. The
electrical stimulation therapy is in need of a new mode of delivery to remove barriers to clinical
implementation, which we offer by means of novel transient bio-electric implant system. Overall,
this proposal will deliver a new horizon in how we can improve the treatment of patients with
peripheral nerve injuries to maximize their functional recovery.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3791/63085
发表时间:
2021-10-20
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Wang H, D'Andrea D, Choi YS, Bouricha Y, Wickerson G, Ahn HY, Guo H, Huang Y, Sandhu MS, Jordan SW, Rogers JA, Franz CK]
通讯作者:
Franz CK
DOI:
10.1002/adfm.202102724
发表时间:
2021-05-06
期刊:
ADVANCED FUNCTIONAL MATERIALS
影响因子:
19
作者:
[Guo, Hexia, D'Andrea, Dom, Rogers, John A.]
通讯作者:
Rogers, John A.
海外基金